Global Influenza Diagnostics Market 2019-2023
SKU ID : TNV-14439853 | Publishing Date : 08-Jul-2019 | No. of pages : 143
Detailed TOC of Global Influenza Diagnostics Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: SEGMENTATION BY END-USER
PART 07: SEGMENTATION BY INDICATION
PART 08: MARKET SEGMENTATION BY PRODUCT
Market segmentation by product
Comparison by product
Point-of-care testing - Market size and forecast 2018-2023
Immunodiagnostics - Market size and forecast 2018-2023
Molecular diagnostics - Market size and forecast 2018-2023
Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 11: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 12: MARKET TRENDS
Surge in number of genetic characterization studies on influenza virus
Increasing approvals of influenza diagnostic products by regulatory authorities
Rising adoption of rapid diagnostic products in physician office laboratories
PART 13: VENDOR LANDSCAPE
Overview
Landscape disruption
PART 14: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Abbott Laboratories
bioMérieux SA
Bio-Rad Laboratories Inc.
Danaher Corp.
Thermo Fisher Scientific Inc.
PART 15: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
Exhibit 01: Years in consideration
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market characteristics analysis
Exhibit 06: Market segments
Exhibit 07: Market definition - Inclusions and exclusions checklist
Exhibit 08: Market size 2018
Exhibit 09: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 10: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 11: Five forces analysis 2018
Exhibit 12: Five forces analysis 2023
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2018
Exhibit 19: Influenza A diagnostic product in commercial market space:
Exhibit 20: Product - Market share 2018-2023 (%)
Exhibit 21: Comparison by product
Exhibit 22: Point-of-care testing - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Point-of-care testing - Year-over-year growth 2019-2023 (%)
Exhibit 24: Immunodiagnostics - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Immunodiagnostics - Year-over-year growth 2019-2023 (%)
Exhibit 26: Molecular diagnostics - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Molecular diagnostics - Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Customer landscape analysis
Exhibit 31: Market share by geography 2018-2023 (%)
Exhibit 32: Geographic comparison
Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: North America - Year-over-year growth 2019-2023 (%)
Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Decision framework
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Exhibit: Nucleic acid detection-based US FDA-cleared influenza diagnostics test in commercial market (as of 2019)
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendor landscape analysis
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Abbott Laboratories - Vendor overview
Exhibit 53: Abbott Laboratories - Business segments
Exhibit 54: Abbott Laboratories - Organizational developments
Exhibit 55: Abbott Laboratories - Geographic focus
Exhibit 56: Abbott Laboratories - Segment focus
Exhibit 57: Abbott Laboratories - Key offerings
Exhibit 58: bioMérieux SA - Vendor overview
Exhibit 59: bioMérieux SA - Business segments
Exhibit 60: bioMérieux SA - Organizational developments
Exhibit 61: bioMérieux SA - Geographic focus
Exhibit 62: bioMérieux SA - Key offerings
Exhibit 63: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 64: Bio-Rad Laboratories Inc. - Business segments
Exhibit 65: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 66: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 67: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 68: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 69: Danaher Corp. - Vendor overview
Exhibit 70: Danaher Corp. - Business segments
Exhibit 71: Danaher Corp. - Organizational developments
Exhibit 72: Danaher Corp. - Geographic focus
Exhibit 73: Danaher Corp. - Segment focus
Exhibit 74: Danaher Corp. - Key offerings
Exhibit 75: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 76: Thermo Fisher Scientific Inc. - Business segments
Exhibit 77: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 78: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 79: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 80: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 81: Validation techniques employed for market sizing
Exhibit 82: List of abbreviations
Exhibit 83: Definition of market positioning of vendors